IGF1 and type 2 diabetes mellitus: The IGF-I/ PI3K/AKT signaling cascade directly inhibits skeletal muscle autophagy16, and as this pathway is dysregulated in skeletal muscle from T2DM individuals17, it is plausible that dysfunctional insulin signaling may lead to altered autophagy levels in skeletal muscle in type 2 diabetes.